Clinical trials
Infection Prevention clinical trials
Below are recruiting infection prevention clinical trials, each written for real people, not researchers. We’re tracking 131 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06980480RecruitingPhase 3
Gammagard to prevent infections in multiple myeloma
This study tests if adding Gammagard (a type of antibody therapy) to your multiple myeloma treatment with Tecvayli can help prevent serious infections. You may qualify if you recently started Tecvayli and are still responding to it.
Mobile, AlabamaAges 18 years+ - NCT06976476RecruitingPhase 2
IgPro20 to prevent infections in multiple myeloma patients on bispecific therapy
This study tests whether a weekly infusion of a blood product called IgPro20 can help prevent infections in people with multiple myeloma who are already being treated with a bispecific antibody. If you qualify, you will receive the study treatment and be monitored for safety and infection rates.
Atlanta, GeorgiaAges 18 years+ - NCT05952804RecruitingPhase 2
IVIG to help prevent infections after CAR-T treatment
This Phase 2 study tests whether IVIG (a blood product that helps fight infections) can lower infection risk after you receive CD19 CAR-T therapy. It’s meant to help protect you during the vulnerable period after CAR-T treatment.
Duarte, CaliforniaAges 18 years+ - NCT05775614Enrolling by invitation
Catheter care rinse study to prevent infections and improve comfort
This study tests a catheter “rinse” product (UroTainer) or plain saline to help keep a permanent catheter working and reduce infection risk. It also looks at comfort and quality of life for people who have had catheter problems like blockage or buildup.
OdenseAges 18 years+ - NCT05421741RecruitingPhase 4
Antibiotic-coated nail to help prevent infection
This trial studies a special nail for certain broken shin bones to lower the chance of infection after surgery. If you qualify, the study team will help you receive the antibiotic-coated nail and will follow you closely for about a year.
Gainesville, FloridaAges 18 years+ - NCT06655272RecruitingPhase 4
OM 85 to prevent lung infections in older nursing home residents
This study tests a medication called OM 85 that may help prevent respiratory infections (like pneumonia) in older adults living in nursing homes. If you are 75 or older and have had infections recently, this trial could be a way to stay healthier.
Roma, RMAges 75 years+ - NCT05320835Recruiting
Talk-based overdose prevention for people using opioids
This trial tests an overdose prevention approach for people who have used opioids recently. It aims to help reduce the risk of overdose by offering a structured prevention intervention.
Baltimore, MarylandAges 18 years+ - NCT07834346RecruitingPhase 3
Clarithromycin to prevent new infections in sepsis after pneumonia
This study tests whether an antibiotic called clarithromycin can help prevent additional infections in people who have sepsis from pneumonia. The goal is to see if it helps you recover faster and avoid complications.
Pátrai, AchaeaAges 18 years+ - NCT07086820Recruiting
Window prophylaxis for preventing TB in children
This trial tests if a short course of medication can prevent tuberculosis (TB) in children and teenagers who have been in close contact with someone who has active TB. The goal is to see if this approach can stop them from developing the disease.
Calama, AntofagastaAges 5–17 - NCT05758532RecruitingPhase 4
Modified measles vaccine schedule to help prevent allergies in babies
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
GenevaAges 6 months–6 months - NCT04855773Recruiting
Mobile text-message support to help people stay on PrEP
This trial tests whether phone-based (iPhone/Android) text-message support can improve how consistently people use PrEP, an HIV prevention medicine. It may help you stay on track with refills and clinic visits, especially if you’re at higher risk of stopping PrEP.
San Francisco, CaliforniaAges 15 years+ - NCT07473778Recruiting
Study of Lenacapavir for HIV Prevention
This trial tests a new medication, lenacapavir, to see how well it works for preventing HIV. It is for people who want or need PrEP (a medicine to prevent HIV) and are interested in learning about different options.
Birmingham, AlabamaAges 18 years+ - NCT06872307Recruiting
Helping Black men stay on PrEP
This study tests a new way to help Black men who have sex with men stay on PrEP (HIV prevention pills) over time. If you are at risk for HIV and have stopped taking PrEP for at least a month, you may be able to join and get support to keep taking it.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06778083Recruiting
Antibiotic to prevent STIs and its effect on resistance
This study looks at taking doxycycline to prevent sexually transmitted infections (STIs) in men who have sex with men. It focuses on how this approach might affect the body's resistance to antibiotics.
LondonAges 18 years+ - NCT06003192Recruiting
Screen Smart: Boosting HIV testing in teens
This trial tests a digital health tool to help increase HIV screening and prevention among teenagers visiting the emergency department. If you are 15 to 21 years old, you may be able to join and help improve how we offer these services.
Columbus, OhioAges 15–21 - NCT06370923Recruiting
Using male peer networks for HIV prevention
This study tests if working with groups of male friends can help men better engage with HIV prevention services. It aims to find new ways to reach men who may not otherwise seek prevention tools.
Mutare, Manicaland ProvinceAges 18 years+ - NCT04953130RecruitingPhase 4
HPV vaccine for boys in Tanzania
This trial studies whether giving one dose of the HPV vaccine to boys, in addition to vaccinating girls, helps protect more people from HPV-related cancers. Boys aged 14-18 who live in certain communities in Tanzania may be able to take part.
MwanzaAges 14–18 - NCT06050148RecruitingPhase 2/Phase 3
Fecal Transplant to Prevent Repeat Urinary Tract Infections
This trial tests whether a fecal microbiota transplant (a procedure that transfers healthy bacteria from a donor's stool into your gut) can help prevent repeat urinary tract infections in women who have frequent infections.
HelsinkiAges 18–90 - NCT05959603RecruitingPhase 3
Vancomycin powder during spinal surgery to prevent infection
This Phase 3 trial tests whether placing vancomycin powder in the wound during spinal fusion surgery can lower the chance of a surgical site infection. You might qualify if you’re having a specific type of spinal surgery and meet safety criteria.
Petah TikvaAges 18–90 - NCT03083184RecruitingPhase 3
Ethanol lock solution to prevent catheter infections
This Phase 3 study tests whether a medicine-filled “lock” put into a dialysis catheter can lower the risk of infections. It is meant for people on regular dialysis with a tunnelled catheter who already have it in place.
Clermont-FerrandAges 18 years+ - NCT07186244Recruiting
HIV Prevention Study for People Starting or Taking PrEP
This study is for people who are HIV-negative and want to take PrEP (a daily pill that prevents HIV). It will help researchers learn more about how to best support people taking PrEP in real-world settings.
Chieti, AbruzzoAges 18 years+ - NCT06285357Recruiting
Testing EGCG, folic acid, and vitamin B12 for HPV
This trial tests whether taking a combination of EGCG (a compound from green tea), folic acid, and vitamin B12 can help prevent an HPV infection from lasting or getting worse. You may be able to join if you have a high-risk HPV infection but not a more serious cervical cell change called HSIL.
Modena, ModenaAges 25–65 - NCT05913180RecruitingPhase 2
Vitamin C to prevent urine infections after gynecologic surgery
This Phase 2 study tests whether taking vitamin C can lower the chance of getting a urinary tract infection (UTI) after planned gynecologic surgery. It may help people who want to reduce post-surgery infection risk.
MoscowAges 18–80 - NCT07500415Recruiting
Doxycycline to prevent STIs in Rio de Janeiro
This trial tests whether taking the antibiotic doxycycline can prevent sexually transmitted infections (STIs) like chlamydia, gonorrhea, and syphilis in people at higher risk. If you are a man or transgender woman who has sex with men, are living with HIV or on PrEP, and have had an STI in the past year, you may be able to join.
Rio de Janeiro, Rio de JaneiroAges 18 years+
Hear when a new Infection Prevention trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infection prevention?
- Yes. Clin2 currently lists 131 recruiting infection prevention studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infection prevention trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infection prevention trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.